Related Experiment Video
Updated: Apr 26, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Breastfeeding duration and asthma in Puerto Rican children
Christian Rosas-Salazar1, Erick Forno2, John M Brehm2
1Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University, Nashville, Tennessee.
Insights
Breastfeeding for up to six months is linked to a 30% reduction in asthma odds for Puerto Rican children. Longer breastfeeding durations did not show additional asthma protection in this population.
Area of Science:
- Pediatric Asthma Research
- Epidemiology
- Public Health Nutrition
Background:
- Asthma disproportionately affects Puerto Rican children in the US.
- Limited data exists on breastfeeding's impact on asthma within this demographic.
Purpose of the Study:
- To investigate the association between breastfeeding duration and asthma in school-aged Puerto Rican children.
- To evaluate if current breastfeeding recommendations align with asthma risk reduction in this population.
Main Methods:
- A case-control study involving 1,127 Puerto Rican children aged 6-14.
- Parental recall of breastfeeding categorized as none, 0-6 months, or >6 months.
- Asthma defined by physician diagnosis and wheezing; logistic regression used for analysis, adjusting for multiple covariates.
Main Results:
- Breastfeeding up to 6 months was associated with a 30% decrease in asthma odds (P=0.04).
- Breastfeeding longer than 6 months showed no significant association with reduced asthma risk (P=0.06).
Conclusions:
- Breastfeeding for up to 6 months is associated with lower asthma odds in Puerto Rican children.
- Extended breastfeeding beyond 6 months did not provide additional asthma-protective benefits.
- Findings support current recommendations for breastfeeding duration in high-risk ethnic groups.
Rationale:
Little is known about breastfeeding and asthma in Puerto Ricans, the ethnic group most affected by this disease in the US. We examined the relation between the currently recommended duration of breastfeeding and asthma in school-aged Puerto Rican children.
Methods:
Case-control study of 1,127 Puerto Rican children aged 6-14 years living in Hartford, Connecticut (n = 449) and San Juan, Puerto Rico (n = 678). Parental recall of breastfeeding was categorized based on duration and according to current guidelines (i.e., none, 0-6 months, and >6 months). Asthma was defined as parental report of physician-diagnosed asthma and wheeze in the previous year. We used logistic regression for the multivariate analysis, which was conducted separately for each study site and for the combined cohort. All multivariate models were adjusted for age, gender, household income, atopy, maternal asthma, body mass index, early-life exposure to environmental tobacco smoke, and (for the combined cohort) study site.
Results:
After adjustment for covariates, children who were breastfed for up to 6 months had 30% lower odds of asthma (95% CI = 0.5-1.0, P = 0.04) than those who were not breastfed. In this analysis, breastfeeding for longer than 6 months was not significantly associated with asthma (OR = 1.5, 95% CI = 1.0-2.4, P = 0.06).
Conclusions:
Our results suggest that breastfeeding for up to 6 months (as assessed by parental recall) is associated with decreased odds of asthma in Puerto Rican children, and that there is no additional beneficial effect of breastfeeding for over 6 months. These results support current recommendations on the duration of breastfeeding in an ethnic group at risk for asthma.
More Related Videos
08:12Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
05:04A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
Published on: September 22, 2023
Related Concept Videos
Asthma-IV: Nursing Management
First, in...
Asthma III: Clinical Manifestations
Asthma-I: Introduction
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction